Add-on Acquisition • Life Science

Inotiv Acquires Bolder BioPATH

On April 16, 2021, Inotiv acquired life science company Bolder BioPATH for 20M USD

Acquisition Context
  • This is Inotiv’s 4th transaction in the Life Science sector.
  • This is Inotiv’s 3rd largest (disclosed) transaction.
  • This is Inotiv’s 4th transaction in the United States.
  • This is Inotiv’s 2nd transaction in Colorado.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date April 16, 2021
Target Bolder BioPATH
Sector Life Science
Buyer(s) Inotiv
Deal Type Add-on Acquisition
Deal Value 20M USD

Target Company

Bolder BioPATH

Boulder, Colorado, United States
Bolder BioPATH is a contract pharmacology and pathology company specializing in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of the central nervous system, and other autoimmune, inflammation, and pain models. Bolder BioPATH was founded in 2003 and is based in Boulder, Colorado.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Inotiv

West Lafayette, Indiana, United States

Category Company
Founded 1974
Sector Life Science
Employees1,977
Revenue 491M USD (2024)
DESCRIPTION

Inotiv is a pharmaceutical development company providing contract research services and niche instrumentation, serving both the life sciences industries, primarily in drug research and development. Inotiv was founded in 1974 and is based in West Lafayette, Indiana.


Deal Context for Buyer #
Overall 4 of 9
Sector: Life Science 4 of 8
Type: Add-on Acquisition 3 of 7
State: Colorado 2 of 3
Country: United States 4 of 9
Year: 2021 2 of 3
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-13 HistoTox Labs

Boulder, Colorado, United States

HistoTox Labs is a full-service histopathology contract research organization (CRO) offering medically relevant non-clinical and clinical services to the pharmaceutical, biotech, and academic communities.

Buy $22M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-04 Plato BioPharma

Westminster, Colorado, United States

Plato BioPharma is a biotechnology company that engages in vivo pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary, and hepatic therapeutic areas. Plato BioPharma was founded in 2009 and is based in Westminster, Colorado.

Buy $15M